Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioxcel Therapeutics Inc (NQ: BTAI )

3.570 -0.140 (-3.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 526,571
Open 3.690
Bid (Size) 3.550 (2)
Ask (Size) 3.710 (3)
Prev. Close 3.710
Today's Range 3.570 - 3.780
52wk Range 2.230 - 34.12
Shares Outstanding 29,272,671
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unlocking AI investment opportunities in healthcare
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence

Performance

YTD
-83.36%
-83.36%
1 Month
-25.47%
-25.47%
3 Month
+1.71%
+1.71%
6 Month
-82.95%
-82.95%
1 Year
-80.57%
-80.57%

More News

Read More
Expert Ratings for BioXcel Therapeutics
Via Benzinga
Why Is Dementia Focused BioXcel Therapeutics Stock Trading Lower Today?
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Recap: BioXcel Therapeutics Q3 Earnings
Via Benzinga
Earnings Outlook For BioXcel Therapeutics
Via Benzinga
Where BioXcel Therapeutics Stands With Analysts
Via Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Shell Layoffs 2023: What to Know About the Latest SHEL Job Cuts
Via InvestorPlace
Topics Energy Workforce
Exposures Fossil Fuels Layoff
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
EVGO Stock Slips as TD Cowen Downgrades EVgo
Via InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
Via Benzinga
Why Shares of BioXcel Therapeutics Fell This Week
Via The Motley Fool
Topics Workforce
Exposures Layoff
NASDAQ: BTAI Investor Alert: Deadline on September 5, 2023 in Lawsuit Against BioXcel Therapeutics, Inc.
Via SBWire
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.